gvtcx

Provision of Fully Integrated Molecular Diagnostic System (NeuMoDX96)

Public Health England Published 14 Jan 2020 Contracts Finder
The value below is a framework or dynamic market ceiling: the maximum that could be spent across all call-offs, not the value of a single contract. Aggregate figures on this site exclude these to avoid double counting.

key details

Value£600,000
Statuscomplete
Category (CPV) 33124110
Deadline30 Dec 2019
Contract start31 Dec 2019
Contract end31 Dec 2024
Procedureselective
SME suitableYes
OCIDocds-b5fd17-9e93e7a9-74e1-4b5d-bcbf-050f4373e224

Award

SupplierValueDateStatus
QIAGEN LIMITED £600,000 31 Dec 2019 active

description

Public Health England (PHE) has awarded a contract for the provision of Fully Integrated Molecular Diagnostic System (NeuMoDX96) to Qiagen Ltd. The contract also covers associated software, assays, reagents and consumables.

The contract is a direct award under Lot 1 (Diagnostics) of PHE Microbiology Framework and it is for 5 years with 2 possible extensions of 12 months each. The initial requirement is for Virus Reference Department of National Infection Service (NIS) in Colindale but further instruments may be purchase for this or other labs during the term of the contract.

notice history

1 notice published against this procurement.

PublishedTypeRegimeNotice
14 Jan 2020 Award (award) · 82e5b6e7-0064-41cf-84d2-7490ba304943-337158

more from Public Health England

all contracts from this buyer →

similar contracts awarded

Other awarded contracts in the same category. Useful for seeing who normally wins this kind of work, and at what value.

source

Published on Contracts Finder. Contact details for named individuals are not reproduced on this site.